Universitätsklinikum Magdeburg A.ö.R. Institut für Humangenetik
170 capabilities
Accredited since June 2025
Verified Apr 2026
One of 3,039 in Germany
Details
Leipziger Straße 44
Magdeburg 39120 , Germany
Magdeburg 39120 , Germany
Accreditation
Active
DAkkS
D-ML-13264-04-00
Offers human genetic testing combining molecular diagnostics and cytogenetic analysis, including SNP array-based chromosome analysis and PCR sequencing for genetic variant detection in blood and tissue samples.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-13264-04-00
Status
ActiveSince
20 June 2025
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDFSend an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.
Test Capabilities (170)
| Standard Reference | Description | Category |
|---|---|---|
| C9ORF72 | C9orf72 | Elemental Analysis |
| Cowden Syndrom | Cowden Syndrom | Elemental Analysis |
| Familiäre Hypercholesterinämie | Familiäre Hypercholesterinämie | Elemental Analysis |
| GLA; Morbus Fabry | GLA; Morbus Fabry | Elemental Analysis |
| (BWS) | Wiedemann-Syndrom (BWS): 11p15 | Molecular Diagnostics / PCR |
| (CCM2, KRIT1, PDCD10); SNV, CNV | (CCM2, KRIT1, PDCD10); SNV, CNV | Molecular Diagnostics / PCR |
| (CNV), Validierung von CNV | (CNV), Validierung von CNV | Molecular Diagnostics / PCR |
| (COL3A1); SNV, CNV | (COL3A1); SNV, CNV | Molecular Diagnostics / PCR |
| (DMD/BMD): DMD-Gen | (DMD/BMD): DMD-Gen | Molecular Diagnostics / PCR |
| (FXTAS) | Ataxie-Syndrom (FXTAS): FMR1 | Molecular Diagnostics / PCR |
| (MEN1): MEN1 | (MEN1): MEN1 | Molecular Diagnostics / PCR |
| (MEN2): RET | Neoplasie Typ 2 (MEN2) | Molecular Diagnostics / PCR |
| (PWS)WS/Angelman-Syndrom (AS) | (PWS)WS/Angelman-Syndrom (AS) | Molecular Diagnostics / PCR |
| (R3527H, R3558H), LPA, LDLR, PCSK9, LDLRAP1 | (R3527H, R3558H), LPA, LDLR, PCSK9, LDLRAP1 | Molecular Diagnostics / PCR |
| (SNV), Validierung von SNV | (SNV), Validierung von SNV | Molecular Diagnostics / PCR |
| 6q24.2, 7p12.2, 7q32.2, 11p15.5, 15q11.2, 19q13.43, 20q13.32 | 6q24.2, 7p12.2, 7q32.2, 11p15.5, 15q11.2, 19q13.43, 20q13.32 | Molecular Diagnostics / PCR |
| APC, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PMS2, POLD1, POLE,PTCH1, SMARCE1, SUFU, TP53, NF1, NF2, TSC1, TSC2 | APC, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PMS2, POLD1, POLE,PTCH1, SMARCE1, SUFU, TP53, NF1, NF2, TSC1, TSC2 | Molecular Diagnostics / PCR |
| Adrenogenitales Syndrom (AGS) | Adrenogenitales-Syndrom (AGS) | Molecular Diagnostics / PCR |
| Albinismus (AP3B1, BLOC1S3, BLOC1S6,TYRP1); SNV, CNV | Albinismus (AP3B1, BLOC1S3, BLOC1S6,TYRP1); SNV, CNV | Molecular Diagnostics / PCR |
| Alzheimer'sche Erkrankung (APOE, PSEN1, PSEN2); SNV, CNV | Alzheimer'sche Erkrankung (APOE, PSEN1, PSEN2); SNV, CNV | Molecular Diagnostics / PCR |
| Alzheimer'sche Erkrankung: APOE | Alzheimer'sche Erkrankung: APOE | Molecular Diagnostics / PCR |
| Amyotrophe Lateralsklerose (ALS): | Amyotrophe Lateralsklerose (ALS): | Molecular Diagnostics / PCR |
| Analyse (WES-Panel); SNV, CNV | Analyse (WES-Panel); SNV, CNV | Molecular Diagnostics / PCR |
| Ankerstörungen (GPAA1, PGAP1, PGAP2,PIGY); SNV, CNV | Ankerstörungen (GPAA1, PGAP1, PGAP2,PIGY); SNV, CNV | Molecular Diagnostics / PCR |
| Anämie, megaloblastär (ABCD4, AMN,UMPS); SNV, CNV | Anämie, megaloblastär (ABCD4, AMN,UMPS); SNV, CNV | Molecular Diagnostics / PCR |
| Aortenaneurysma (ABCC6, ACTA2, ACVR1,ZNF469); SNV, CNV | Aortenaneurysma (ABCC6, ACTA2, ACVR1,ZNF469); SNV, CNV | Molecular Diagnostics / PCR |
| Arteriopathie mit subkortikalen | Arteriopathie mit subkortikalen | Molecular Diagnostics / PCR |
| Arthrogrypose (ACTA1, ADCY6, ADGRG6,ZC4H2); SNV, CNV | Arthrogrypose (ACTA1, ADCY6, ADGRG6,ZC4H2); SNV, CNV | Molecular Diagnostics / PCR |
| Augenerkrankungen (ABCA4, ABCB6, ABHD12,ZNF469); SNV, CNV | Augenerkrankungen (ABCA4, ABCB6, ABHD12,ZNF469); SNV, CNV | Molecular Diagnostics / PCR |
| Autoinflammatorische Syndrome | Autoinflammatorische Syndrome | Molecular Diagnostics / PCR |
| Bindegewebserkrankungen inkl. | Bindegewebserkrankungen inkl. | Molecular Diagnostics / PCR |
| Blutbildungsdefekte (ABCB6, ABCB7, ABCD4,ZCCHC8); SNV, CNV | Blutbildungsdefekte (ABCB6, ABCB7, ABCD4,ZCCHC8); SNV, CNV | Molecular Diagnostics / PCR |
| Brust- und Eierstockkrebs | Familiärer Brust- und Eierstockkrebs | Molecular Diagnostics / PCR |
| CL3N58, CL3N59 (ZNF9-Gen) | CL3N58, CL3N59 (ZNF9-Gen) | Molecular Diagnostics / PCR |
| CNV | FMR1 [OMIM*309550], AFF2 [OMIM*300806]; SNV, CNV | Molecular Diagnostics / PCR |
| Cerebral cavernous malformations | Cerebral cavernous malformations | Molecular Diagnostics / PCR |
| Cerebrale Mikroangiopathien inkl. | Cerebrale Mikroangiopathien inkl. | Molecular Diagnostics / PCR |
| Cholestase (ABCB11, ABCB4, ABCC12,VPS33B); SNV, CNV | Cholestase (ABCB11, ABCB4, ABCC12,VPS33B); SNV, CNV | Molecular Diagnostics / PCR |
| Chorea Huntington | HD; Chorea Huntington | Molecular Diagnostics / PCR |
| Chromosomeninstabilitätssyndrome | Chromosomeninstabilitätssyndrome | Molecular Diagnostics / PCR |
| Cystische Fibrose (CF): CFTR | Cystische Fibrose (CF): CFTR | Molecular Diagnostics / PCR |
| Darmkrebs (CRC), unbestimmt | Darmkrebs (CRC), unbestimmt: | Molecular Diagnostics / PCR |
| Demenzerkrankungen (ADAR, ALS2, ANG,XPR1); SNV, CNV | Demenzerkrankungen (ADAR, ALS2, ANG,XPR1); SNV, CNV | Molecular Diagnostics / PCR |
| Ehlers-Danlos-Syndrom, klassischer | Ehlers-Danlos-Syndrom, klassischer | Molecular Diagnostics / PCR |
| Ehlers-Danlos-Syndrom, vaskulärer | Ehlers-Danlos-Syndrom, vaskulärer | Molecular Diagnostics / PCR |
| Entwicklungsstörungen - X-gebundene | Entwicklungsstörungen - X-gebundene | Molecular Diagnostics / PCR |
| Entwicklungsstörungen - syndromale | Entwicklungsstörungen - syndromale | Molecular Diagnostics / PCR |
| Erkrankungen | Neurodegenrative Erkrankungen | Molecular Diagnostics / PCR |
| Fiebersyndrome, periodisch (ADA2, APOA1,WDR1); SNV, CNV | Fiebersyndrome, periodisch (ADA2, APOA1,WDR1); SNV, CNV | Molecular Diagnostics / PCR |
| Fragiles X-Syndrom (FraX), Prämature | Fragiles X-Syndrom (FraX), Prämature | Molecular Diagnostics / PCR |
| GJB2, GJB6 | GJB2, GJB6 | Molecular Diagnostics / PCR |
| Gefäßmalformationen, regionaler | Gefäßmalformationen, regionaler | Molecular Diagnostics / PCR |
| Genetisch bedingte Adipositas | Genetisch bedingte Adipositas | Molecular Diagnostics / PCR |
| Gliedergürtel-Muskeldystrophien | Gliedergürtelmuskeldystrophien | Molecular Diagnostics / PCR |
| Glut1-Defizienz-Syndrom | Glut1-Defizienz-Syndrom | Molecular Diagnostics / PCR |
| HAMP; erbl. Hämochromatose | HAMP; erbl. Hämochromatose | Molecular Diagnostics / PCR |
| Hereditäre Neuropathie mit Neigung | Hereditäre Neuropathie mit Neigung | Molecular Diagnostics / PCR |
| Hereditäre Sensomotorische Neuropathien | Hereditäre Sensomotorische Neuropathien | Molecular Diagnostics / PCR |
| Hereditäre spastische Paraparesen | Hereditäre spastische Paraparesen | Molecular Diagnostics / PCR |
| Herzfehler, genetisch (AARS2, ABCC9,VCP); SNV, CNV | Herzfehler, genetisch (AARS2, ABCC9,VCP); SNV, CNV | Molecular Diagnostics / PCR |
| Hypogonadotroper Hypogonadismus | Hypogonadotroper Hypogonadismus | Molecular Diagnostics / PCR |
| Hämophilie A (F8); SNV, CNV | Hämophilie A (F8); SNV, CNV | Molecular Diagnostics / PCR |
| Joubert-Syndrom (AHI1, ARL13B, ARL3,ZNF423); SNV, CNV | Joubert-Syndrom (AHI1, ARL13B, ARL3,ZNF423); SNV, CNV | Molecular Diagnostics / PCR |
| Kardiomyopathie (AARS2, ABCC9, ACAD9,TGFB3); SNV, CNV | Kardiomyopathie (AARS2, ABCC9, ACAD9,TGFB3); SNV, CNV | Molecular Diagnostics / PCR |
| Karzinom (HNPCC) (EPCAM, MLH1, MSH2,…, PMS2); SNV, CNV | Karzinom (HNPCC) (EPCAM, MLH1, MSH2,…, PMS2); SNV, CNV | Molecular Diagnostics / PCR |
| Karzinom (HNPCC) (EPCAM, MLH1, MSH3, MSH6, PMS2) | Karzinom (HNPCC) (EPCAM, MLH1, MSH3, MSH6, PMS2) | Molecular Diagnostics / PCR |
| Klippel-Feil-Syndrom (DLL3, GDF3, GDF6,ZIC3); SNV, CNV | Klippel-Feil-Syndrom (DLL3, GDF3, GDF6,ZIC3); SNV, CNV | Molecular Diagnostics / PCR |
| Leukodystrophien, Leukoenzephalopathien | Leukodystrophien, Leukoenzephalopathien | Molecular Diagnostics / PCR |
| Leukämie (JMML) (GNAS, LZTR1, NF1,SPRED1); SNV, CNV | Leukämie (JMML) (GNAS, LZTR1, NF1,SPRED1); SNV, CNV | Molecular Diagnostics / PCR |
| Li Fraumeni Syndrom | Li-Fraumeni-Syndrom | Molecular Diagnostics / PCR |
| Lipodystrophie (AGPAT2, AKT2, BANF1,ZMPSTE24); SNV, CNV | Lipodystrophie (AGPAT2, AKT2, BANF1,ZMPSTE24); SNV, CNV | Molecular Diagnostics / PCR |
| Lymphatische Malformationen | Lymphatische Malformationen | Molecular Diagnostics / PCR |
| Lynch-Syndrom / Hereditäres | Lynch-Syndrom / Hereditäres | Molecular Diagnostics / PCR |
| MD102 (DMPK-Gen) | MD102 (DMPK-Gen) | Molecular Diagnostics / PCR |
| Magen-Ca, unbestimmt (CDH1, EPCAM,PMS2); SNV, CNV | Magen-Ca, unbestimmt (CDH1, EPCAM,PMS2); SNV, CNV | Molecular Diagnostics / PCR |
| Magen-Karzinom, diffuses: CDH1 | Magen-Karzinom, diffuses: CDH1 | Molecular Diagnostics / PCR |
| Makrozephalie, Großwuchs (AKT1, AKT3,UPF3B); SNV, CNV | Makrozephalie, Großwuchs (AKT1, AKT3,UPF3B); SNV, CNV | Molecular Diagnostics / PCR |
| Marfan-Syndrom und Typ 1 | Marfan-Syndrom und Typ 1 | Molecular Diagnostics / PCR |
| MeCP2; Rett-Syndrom | MeCP2; Rett-Syndrom | Molecular Diagnostics / PCR |
| Medulloblastom (APC, BRCA2, CTNNB1,TP53); SNV, CNV | Medulloblastom (APC, BRCA2, CTNNB1,TP53); SNV, CNV | Molecular Diagnostics / PCR |
| Migrationsstörungen (ACTB, ACTG1, ADGRG1,WDR81); SNV, CNV | Migrationsstörungen (ACTB, ACTG1, ADGRG1,WDR81); SNV, CNV | Molecular Diagnostics / PCR |
| Mikrozephalie (AMPD2, ANKLE2, ASNS,ZNF335); SNV, CNV | Mikrozephalie (AMPD2, ANKLE2, ASNS,ZNF335); SNV, CNV | Molecular Diagnostics / PCR |
| Mitochondropathien (AARS2, ABCC8, ABCD1,ZNHIT3); SNV, CNV | Mitochondropathien (AARS2, ABCC8, ABCD1,ZNHIT3); SNV, CNV | Molecular Diagnostics / PCR |
| Mukopolysaccharidose (ABCC8, ADAMTSL2,TPP1); SNV, CNV | Mukopolysaccharidose (ABCC8, ADAMTSL2,TPP1); SNV, CNV | Molecular Diagnostics / PCR |
| Mukoviszidose | Mukoviszidose | Molecular Diagnostics / PCR |
| Multi-Locus-Imprinting Defekt (MLID): | Multi-Locus-Imprinting Defekt (MLID): | Molecular Diagnostics / PCR |
| Multiple Endokrine Neoplasie Typ | Multiple endokrine Neoplasie Typ | Molecular Diagnostics / PCR |
| Muskeldystrophie Duchenne/Becker | Muskeldystrophie Duchenne/Becker | Molecular Diagnostics / PCR |
| Muskeldystrophie, kongenitale | Muskeldystrophie, kongenitale | Molecular Diagnostics / PCR |
| Myotone Dystrophie Typ 1 (DM1): | Myotone Dystrophie Typ 1 (DM1): | Molecular Diagnostics / PCR |
| Nephrotisches Syndrom (ACE, COQ8B,WT1); SNV, CNV | Nephrotisches Syndrom (ACE, COQ8B,WT1); SNV, CNV | Molecular Diagnostics / PCR |
| Neuromuskuläre Erkrankungen | Neuromuskuläre Erkrankungen | Molecular Diagnostics / PCR |
| Neuropathien, Motoneuropathien | Neuropathien, Motoneuropathien | Molecular Diagnostics / PCR |
| Nicht-Polypöses Kolorektales | Nicht-Polypöses Kolorektales | Molecular Diagnostics / PCR |
| Optikusatrophie (ACO2, AFG3L2, C12orf65,YME1L1); SNV, CNV | Optikusatrophie (ACO2, AFG3L2, C12orf65,YME1L1); SNV, CNV | Molecular Diagnostics / PCR |
| Osteogenesis imperfecta (OI) (ALPL, ATP6V0A2,WNT1); SNV, CNV | Osteogenesis imperfecta (OI) (ALPL, ATP6V0A2,WNT1); SNV, CNV | Molecular Diagnostics / PCR |
| PROS1 | PROS1 | Molecular Diagnostics / PCR |
| PRRT2 | PRRT2 | Molecular Diagnostics / PCR |
| Pankreas-Ca assoziierte Syndrome | Pankreas-Ca assoziierte Syndrome | Molecular Diagnostics / PCR |
| Pankreatitis | Pankreatitis | Molecular Diagnostics / PCR |
| Periventrikuläre noduläre Heterotopie | Periventrikuläre noduläre Heterotopie | Molecular Diagnostics / PCR |
| Phäochromozytom, Paragangliom | Phäochromozytom, Paragangliom | Molecular Diagnostics / PCR |
| Prostata-Ca, unbestimmt (ATM, BRCA2,…, PMS2); SNV, CNV | Prostata-Ca, unbestimmt (ATM, BRCA2,…, PMS2); SNV, CNV | Molecular Diagnostics / PCR |
| Proximale Myotone Myopathie | Proximale Myotone Myopathie | Molecular Diagnostics / PCR |
| Prämature Ovarialinsuffizienz (POI) | Prämature Ovarialinsuffizienz (POI) | Molecular Diagnostics / PCR |
| Rasopathien, fetales RASopathie-Syndrom | Rasopathien, fetales RASopathie-Syndrom | Molecular Diagnostics / PCR |
| Rhythmusstörungen (ABCC9, AKAP9, ANK2,TTN); SNV, CNV | Rhythmusstörungen (ABCC9, AKAP9, ANK2,TTN); SNV, CNV | Molecular Diagnostics / PCR |
| SNRPN-Region 15q11-13 UPD15 | SNRPN-Region 15q11-13 UPD15 | Molecular Diagnostics / PCR |
| Schwerhörigkeit, nicht syndromal | Schwerhörigkeit, nicht-syndromal: | Molecular Diagnostics / PCR |
| Sensorineutrale Schwerhörigkeit | Sensorineutrale Schwerhörigkeit | Molecular Diagnostics / PCR |
| Serratiertes Polyposis-Syndrom | Serratiertes Polyposis-Syndrom | Molecular Diagnostics / PCR |
| Small fiber neuropathy (SFN) (ATL1, CAV3,GBA); SNV, CNV | Small fiber neuropathy (SFN) (ATL1, CAV3,GBA); SNV, CNV | Molecular Diagnostics / PCR |
| Spinale Muskelatrophie (SMA) | Spinale Muskelatrophie (SMA): | Molecular Diagnostics / PCR |
| Spinalparalysen und Differenzialdiagnosen | Spinalparalysen und Differenzialdiagnosen | Molecular Diagnostics / PCR |
| Spinobulbäre Muskelatrophie (SBMA): | Spinobulbäre Muskelatrophie (SBMA): | Molecular Diagnostics / PCR |
| Spinozerebelläre Ataxie (SCA1, SCA6, SCA7, SCA11): ATXN1, ATXN2, ATXN3, CACNA1A, ATXN7, TBP | Spinozerebelläre Ataxie (SCA1, SCA6, SCA7, SCA11): ATXN1, ATXN2, ATXN3, CACNA1A, ATXN7, TBP | Molecular Diagnostics / PCR |
| Stoffwechselstörungen inkl. | Stoffwechselstörungen inkl. | Molecular Diagnostics / PCR |
| Syndrom und Rett-like-Syndrom | Syndrom und Rett-like-Syndrom | Molecular Diagnostics / PCR |
| Syndrom, MCAP-Syndrom (AKT1, ELMO2,VHL); SNV, CNV | Syndrom, MCAP-Syndrom (AKT1, ELMO2,VHL); SNV, CNV | Molecular Diagnostics / PCR |
| Syndrom, juvenile myelomonozytäre | Syndrom, juvenile myelomonozytäre | Molecular Diagnostics / PCR |
| Thrombophilie Proteil-S-Mangel | Thrombophilie Proteil-S-Mangel | Molecular Diagnostics / PCR |
| Thrombophilie Protein-C-Mangel | Thrombophilie Protein-C-Mangel | Molecular Diagnostics / PCR |
| Tooth Neuropathie Typ 1A (CMT1A, HMSN1A): 17p12 | Tooth Neuropathie Typ 1A (CMT1A, HMSN1A): 17p12 | Molecular Diagnostics / PCR |
| Tuberöse Sklerose Typ 1 und Typ | Tuberöse Sklerose Typ 1 und Typ | Molecular Diagnostics / PCR |
| Tumorprädisposition (ABRAXAS1, AKT1,XRCC2); SNV, CNV | Tumorprädisposition (ABRAXAS1, AKT1,XRCC2); SNV, CNV | Molecular Diagnostics / PCR |
| Tumorprädisposition (AKT1, APC, ATM,TP53); SNV, CNV | Tumorprädisposition (AKT1, APC, ATM,TP53); SNV, CNV | Molecular Diagnostics / PCR |
| UPD14: 14q32 | UPD14: 14q32 | Molecular Diagnostics / PCR |
| UPD6: 6q24 | UPD6: 6q24 | Molecular Diagnostics / PCR |
| UPD7: 7p12, 7q32 | UPD7: 7p12, 7q32 | Molecular Diagnostics / PCR |
| Untersuchung auf familiäre Varianten | Untersuchung auf familiäre Varianten | Molecular Diagnostics / PCR |
| Wilms-Tumor, Denys-Drash-Syndrom: | Wilms-Tumor, Denys-Drash-Syndrom: | Molecular Diagnostics / PCR |
| X-Inaktivierung (XCI): FMR1, AR, | X-Inaktivierung (XCI): FMR1, AR, | Molecular Diagnostics / PCR |
| Ziliopathien (ACVR2B, AHI1, ALMS1,ZNF423); SNV, CNV | Ziliopathien (ACVR2B, AHI1, ALMS1,ZNF423); SNV, CNV | Molecular Diagnostics / PCR |
| assoziierte Polyposis (MAP), juvenile | assoziierte Polyposis (MAP), juvenile | Molecular Diagnostics / PCR |
| hereditäre Lymphödeme, inkl. pränatale | hereditäre Lymphödeme, inkl. pränatale | Molecular Diagnostics / PCR |
| isolierte, Skaphokephalie, isolierte: | isolierte, Skaphokephalie, isolierte: | Molecular Diagnostics / PCR |
| kongenitaler Hyperinsulinismus | kongenitaler Hyperinsulinismus | Molecular Diagnostics / PCR |
| spastische Paraplegien (SPG), spastische | spastische Paraplegien (SPG), spastische | Molecular Diagnostics / PCR |
| syndromal (ADGRV1, AIFM1, ALMS1,WHRN); SNV, CNV | syndromal (ADGRV1, AIFM1, ALMS1,WHRN); SNV, CNV | Molecular Diagnostics / PCR |
| thorakale Aortenerweiterung (ACTA2, COL3A1, FBN1,TGFBR2); SNV, CNV | thorakale Aortenerweiterung (ACTA2, COL3A1, FBN1,TGFBR2); SNV, CNV | Molecular Diagnostics / PCR |
| und Differentialdiagnosen (ABHD5, ACADM, ACADS,YARS2); SNV, CNV | und Differentialdiagnosen (ABHD5, ACADM, ACADS,YARS2); SNV, CNV | Molecular Diagnostics / PCR |
| young (MODY) (ABCC8, AKT2, APPL1,TRMT10A); SNV, CNV | young (MODY) (ABCC8, AKT2, APPL1,TRMT10A); SNV, CNV | Molecular Diagnostics / PCR |
| zerebrale autosomal-dominante | zerebrale autosomal-dominante | Molecular Diagnostics / PCR |
| (Exon 7 und 8), SMN2 (Exon 7 und | (Exon 7 und 8), SMN2 (Exon 7 und | Other |
| 2143delT, 2184delA, 3272-26A>G, G85E, 621+1G>T, 3659delC, R334W, 1677delTA, 1078delT, E92*, 3905insT, E60*, I336K, 2184insA, A455E, Y1092*) | 2143delT, 2184delA, 3272-26A>G, G85E, 621+1G>T, 3659delC, R334W, 1677delTA, 1078delT, E92*, 3905insT, E60*, I336K, 2184insA, A455E, Y1092*) | Other |
| AARS1, ABCA1,YARS1); SNV, CNV | AARS1, ABCA1,YARS1); SNV, CNV | Other |
| AARS1, ABCC9,ZFHX2); SNV, CNV | AARS1, ABCC9,ZFHX2); SNV, CNV | Other |
| AARS2, ABCB7,ZNHIT3); SNV, CNV | AARS2, ABCB7,ZNHIT3); SNV, CNV | Other |
| ACVR1, ADSS1,YARS2); SNV, CNV | ACVR1, ADSS1,YARS2); SNV, CNV | Other |
| ADRB2, ADRB3,WDPCP); SNV, CNV | ADRB2, ADRB3,WDPCP); SNV, CNV | Other |
| ARX, ASXL1,ZEB2); SNV, CNV | ARX, ASXL1,ZEB2); SNV, CNV | Other |
| ATM, ATR,ZBTB24); SNV, CNV | ATM, ATR,ZBTB24); SNV, CNV | Other |
| ATM, BRCA1,…,TP53); SNV, CNV | ATM, BRCA1,…,TP53); SNV, CNV | Other |
| AXIN2,STK11); SNV, CNV | AXIN2,STK11); SNV, CNV | Other |
| Allel), APP (Exon 16 und 17) | Allel), APP (Exon 16 und 17) | Other |
| BAP1, CDC73,VHL); SNV, CNV | BAP1, CDC73,VHL); SNV, CNV | Other |
| BMPR1A, MUTYH, NTHL1, POLD1, SMAD4, STK11) | BMPR1A, MUTYH, NTHL1, POLD1, SMAD4, STK11) | Other |
| CARD8, CD70,WDR1); SNV, CNV | CARD8, CD70,WDR1); SNV, CNV | Other |
| CHCHD10, FUS,…, VCP); SNV, CNV | CHCHD10, FUS,…, VCP); SNV, CNV | Other |
| CHEK2, PALB2, PTEN, RAD51C, STK11, TP53) | CHEK2, PALB2, PTEN, RAD51C, STK11, TP53) | Other |
| Epilepsie (AARS1, ABAT, ACY1,…, SNV, CNV | Epilepsie (AARS1, ABAT, ACY1,…, SNV, CNV | Other |
| Fibrillinopathien (FBN1, TGFBR1, SNV, CNV | Fibrillinopathien (FBN1, TGFBR1, SNV, CNV | Other |
| Hauptmutationen (N1303K, F508del, R553*, G542*, G551D, R347P, 3849+10kb | Hauptmutationen (N1303K, F508del, R553*, G542*, G551D, R347P, 3849+10kb | Other |
| Hereditäres | SERPING1, F12 (Hereditäres | Other |
| Kraniosynostosen (ALPL, ALX1, SNV, CNV | Kraniosynostosen (ALPL, ALX1, SNV, CNV | Other |
| Lymphödeme (AKT1, BRAF, CBL,…, SNV, CNV | Lymphödeme (AKT1, BRAF, CBL,…, SNV, CNV | Other |
| Mixed Polyposis-Syndrom (HMPS)) | Mixed Polyposis-Syndrom (HMPS)) | Other |
| PROC | PROC | Other |
| Polyposis-Syndrome (Familiäre | Polyposis-Syndrome (Familiäre | Other |
| Syndrom (MPPH) (AKT3, CCND2, SNV, CNV | Syndrom (MPPH) (AKT3, CCND2, SNV, CNV | Other |